KISQALI 200 mg/1 (Ribociclib TABLET, FILM COATED) 200 mg/1

KISQALI 200 mg is a film-coated tablet used in cancer treatment. It contains ribociclib, a medication often prescribed for specific types of breast cancer. This oral medication is manufactured by Novartis Pharmaceuticals Corporation in the USA.

Strength

200 mg/1

Pack Size

3 BLISTER PACK in 1 CARTON (0078-0874-63) / 21 TABLET, FILM COATED in 1 BLISTER PACK (0078-0874-21)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KISQALI 200 mg is primarily used in the treatment of certain types of breast cancer. It is often prescribed in combination with other medications to help manage the condition. The active ingredient, ribociclib, works by targeting specific proteins involved in cancer cell growth. Patients may wonder, 'What is KISQALI used for?' It is typically used in advanced or metastatic breast cancer cases.

Side Effects

Common effects of KISQALI 200 mg may include fatigue, nausea, and diarrhea. Some patients may experience hair loss or changes in appetite. It is important to discuss any persistent or severe side effects with a healthcare provider. The effects can vary from person to person, and not everyone will experience the same symptoms.

Precautions & Warnings

KISQALI 200 mg should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their doctor about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Avoid Interactions

KISQALI 200 mg may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances may also interact with ribociclib, so it is advisable to discuss any potential interactions with a healthcare professional.

Frequently Asked Questions

KISQALI 200 mg is used in the treatment of certain types of breast cancer, often in combination with other medications.

KISQALI 200 mg is taken orally, typically as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions.

Common side effects may include fatigue, nausea, diarrhea, and hair loss. Patients should discuss any persistent or severe side effects with their healthcare provider.

KISQALI 200 mg may interact with certain medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Pregnant women or those planning to become pregnant should consult their healthcare provider before using KISQALI 200 mg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.